From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review
Kidney transplantation remains the best treatment for chronic kidney failure, offering better outcomes and quality of life compared with dialysis. Cardiovascular disease (CVD) is a major cause of morbidity and mortality in kidney transplant recipients and is associated with decreased patient surviva...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/7/802 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849738815687622656 |
|---|---|
| author | Thomas Beaudrey Dimitri Bedo Célia Weschler Sophie Caillard Nans Florens |
| author_facet | Thomas Beaudrey Dimitri Bedo Célia Weschler Sophie Caillard Nans Florens |
| author_sort | Thomas Beaudrey |
| collection | DOAJ |
| description | Kidney transplantation remains the best treatment for chronic kidney failure, offering better outcomes and quality of life compared with dialysis. Cardiovascular disease (CVD) is a major cause of morbidity and mortality in kidney transplant recipients and is associated with decreased patient survival and worse graft outcomes. Post-transplant CVD results from a complex interaction between traditional cardiovascular risk factors, such as hypertension and diabetes, and risk factors specific to kidney transplant recipients including chronic kidney disease, immunosuppressive drugs, or vascular access. An accurate assessment of cardiovascular risk is now needed to optimize the management of cardiovascular comorbidities through the detection of risk factors and the screening of hidden pretransplant coronary artery disease. Promising new strategies are emerging, such as GLP-1 receptor agonists and SGLT2 inhibitors, with a high potential to mitigate cardiovascular complications, although further research is needed to determine their role in kidney transplant recipients. Despite this progress, a significant gap remains in understanding the optimal management of post-transplant CVD, especially coronary artery disease, stroke, and peripheral artery disease. Addressing these challenges is essential to improve the short- and long-term outcomes in kidney transplant recipients. This narrative review aims to provide a comprehensive overview of cardiovascular risk assessment and post-transplant CVD management. |
| format | Article |
| id | doaj-art-461db3e5fe164f2183ad13a69af10b18 |
| institution | DOAJ |
| issn | 2075-4418 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj-art-461db3e5fe164f2183ad13a69af10b182025-08-20T03:06:27ZengMDPI AGDiagnostics2075-44182025-03-0115780210.3390/diagnostics15070802From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative ReviewThomas Beaudrey0Dimitri Bedo1Célia Weschler2Sophie Caillard3Nans Florens4Nephrology Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, FranceNephrology Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, FranceNephrology Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, FranceNephrology Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, FranceNephrology Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, FranceKidney transplantation remains the best treatment for chronic kidney failure, offering better outcomes and quality of life compared with dialysis. Cardiovascular disease (CVD) is a major cause of morbidity and mortality in kidney transplant recipients and is associated with decreased patient survival and worse graft outcomes. Post-transplant CVD results from a complex interaction between traditional cardiovascular risk factors, such as hypertension and diabetes, and risk factors specific to kidney transplant recipients including chronic kidney disease, immunosuppressive drugs, or vascular access. An accurate assessment of cardiovascular risk is now needed to optimize the management of cardiovascular comorbidities through the detection of risk factors and the screening of hidden pretransplant coronary artery disease. Promising new strategies are emerging, such as GLP-1 receptor agonists and SGLT2 inhibitors, with a high potential to mitigate cardiovascular complications, although further research is needed to determine their role in kidney transplant recipients. Despite this progress, a significant gap remains in understanding the optimal management of post-transplant CVD, especially coronary artery disease, stroke, and peripheral artery disease. Addressing these challenges is essential to improve the short- and long-term outcomes in kidney transplant recipients. This narrative review aims to provide a comprehensive overview of cardiovascular risk assessment and post-transplant CVD management.https://www.mdpi.com/2075-4418/15/7/802cardiovascular diseasekidney transplant recipientsrisk managementdiagnostic strategies |
| spellingShingle | Thomas Beaudrey Dimitri Bedo Célia Weschler Sophie Caillard Nans Florens From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review Diagnostics cardiovascular disease kidney transplant recipients risk management diagnostic strategies |
| title | From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review |
| title_full | From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review |
| title_fullStr | From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review |
| title_full_unstemmed | From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review |
| title_short | From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review |
| title_sort | from risk assessment to management cardiovascular complications in pre and post kidney transplant recipients a narrative review |
| topic | cardiovascular disease kidney transplant recipients risk management diagnostic strategies |
| url | https://www.mdpi.com/2075-4418/15/7/802 |
| work_keys_str_mv | AT thomasbeaudrey fromriskassessmenttomanagementcardiovascularcomplicationsinpreandpostkidneytransplantrecipientsanarrativereview AT dimitribedo fromriskassessmenttomanagementcardiovascularcomplicationsinpreandpostkidneytransplantrecipientsanarrativereview AT celiaweschler fromriskassessmenttomanagementcardiovascularcomplicationsinpreandpostkidneytransplantrecipientsanarrativereview AT sophiecaillard fromriskassessmenttomanagementcardiovascularcomplicationsinpreandpostkidneytransplantrecipientsanarrativereview AT nansflorens fromriskassessmenttomanagementcardiovascularcomplicationsinpreandpostkidneytransplantrecipientsanarrativereview |